project id: TCGA-MESO; case submitter id: TCGA-3H-AB3X; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.9; rna integrity number: 9.3; age at index: 62; days to birth: -22702; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1948; age at diagnosis: 22702; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1490.0; icd 10 code: C34.90; last known disease status: not reported; morphology: 9052/3; primary diagnosis: Epithelioid mesothelioma, malignant; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lung, NOS; synchronous malignancy: No; tissue or organ of origin: Pleura, NOS; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1106; days to sample procurement: 0; initial weight: 60.0; portion submitter id: TCGA-3H-AB3X-01A-11; percent lymphocyte infiltration: 70.0; percent monocyte infiltration: 10.0; percent necrosis: 0.0; percent neutrophil infiltration: 10.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0;